answer text |
<p> </p><p>The Department’s National Institute for Health Research (NIHR) is supporting
neuroblastoma research through NIHR biomedical research centres, the NIHR clinical
research facility at the Royal Marsden Hospital, Experimental Cancer Medicine Centres
(funded jointly with Cancer Research UK) and the NIHR Clinical Research Network. A
study of re-purposing of 13-cis-retinoic acid for use in treating children with neuroblastoma
has recently been approved for funding through the Health Innovation Challenge Fund.
This is a fund jointly supported by the Department and the Wellcome Trust.</p><p>
</p>
|
|